DEA Places Synthetic Drug in Schedule I
The Drug Enforcement Administration permanently placed 2-methyl AP-237, a synthetic drug that acts like an opioid, in Schedule I of the Controlled Substances Act, in a final rule released March 14. New registration, labeling, record-keeping, and import and export requirements…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
under the final rule take effect April 15.